FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2400973399> ?p ?o ?g. }

• W2400973399 endingPage "71" @default.
• W2400973399 startingPage "660" @default.
• W2400973399 abstract "The mechanisms of iron uptake from transferrin and the effects of iron chelators on these processes were investigated in human neuroblastoma cells. This study was performed because numerous reports have indicated that neuroblastoma cells contain iron-rich ferritin and are also especially sensitive to iron chelation by deferoxamine. The mechanisms of iron and transferrin uptake were examined in the human neuroblastoma cell line SK-N-MC by using human transferrin labeled with iodine 125 and iron 59. Internalized and membrane-bound 59Fe and 125I-transferrin were separated with the protease pronase. Total internalized and membrane 125I-transferrin uptake was biphasic with time, whereas total and internalized 59Fe uptake was linear. Iron uptake from transferrin was prevented by incubation at 4 degrees C and also by lysosomotrophic agents. In addition, 59Fe uptake occurred by two processes. The first process was consistent with receptor-mediated endocytosis involving internalization of transferrin bound to specific binding sites. Iron uptake also occurred by a second process, which was not saturable up to a transferrin concentration of 0.06 mg/ml. In terms of quantitative iron uptake, however, the second process was far less important than receptor-mediated endocytosis. Deferoxamine (0.25 mmol/L) only slightly increased 59Fe release from prelabeled cells; the orally effective iron chelator pyridoxal isonicotinoyl hydrazone (0.25 mmol/L) was six times more effective. Moreover, when pyridoxal isonicotinoyl hydrazone (0.2 mmol/L) was added together with labeled transferrin over a 2-hour incubation, 59Fe uptake from transferrin decreased to 18% of the control value, whereas deferoxamine (0.2 mmol/L) had no appreciable effect. Even though deferoxamine (0.1 mmol/L) had little effect on 59Fe uptake or release, it reduced uptake of tritiated thymidine to 33% of the control value after a 24-hour incubation. Three analogs of pyridoxal isonicotinoyl hydrazone, pyridoxal benzoyl hydrazone (#101), pyridoxal p-methoxybenzoyl hydrazone (#107), and pyridoxal m-fluorobenzoyl hydrazone (#109), had chelation activities comparable to that of pyridoxal isonicotinoyl hydrazone and were more effective than either deferoxamine or pyridoxal isonicotinoyl hydrazone at preventing tritiated thymidine uptake. These results suggest that the pyridoxal isonicotinoyl hydrazone analogs have potential as effective antiproliferative agents and deserve further investigation." @default.
• W2400973399 created "2016-06-24" @default.
• W2400973399 creator A5056211046 @default.
• W2400973399 creator A5061763563 @default.
• W2400973399 date "1994-11-01" @default.
• W2400973399 modified "2023-09-23" @default.
• W2400973399 title "The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis." @default.
• W2400973399 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7964124" @default.
• W2400973399 hasPublicationYear "1994" @default.
• W2400973399 type Work @default.
• W2400973399 sameAs 2400973399 @default.
• W2400973399 citedByCount "13" @default.
• W2400973399 countsByYear W24009733992013 @default.
• W2400973399 countsByYear W24009733992014 @default.
• W2400973399 countsByYear W24009733992015 @default.
• W2400973399 countsByYear W24009733992017 @default.
• W2400973399 crossrefType "journal-article" @default.
• W2400973399 hasAuthorship W2400973399A5056211046 @default.
• W2400973399 hasAuthorship W2400973399A5061763563 @default.
• W2400973399 hasConcept C139770010 @default.
• W2400973399 hasConcept C170493617 @default.
• W2400973399 hasConcept C178790620 @default.
• W2400973399 hasConcept C185592680 @default.
• W2400973399 hasConcept C197404232 @default.
• W2400973399 hasConcept C22814914 @default.
• W2400973399 hasConcept C2776672577 @default.
• W2400973399 hasConcept C28005876 @default.
• W2400973399 hasConcept C32264632 @default.
• W2400973399 hasConcept C55493867 @default.
• W2400973399 hasConceptScore W2400973399C139770010 @default.
• W2400973399 hasConceptScore W2400973399C170493617 @default.
• W2400973399 hasConceptScore W2400973399C178790620 @default.
• W2400973399 hasConceptScore W2400973399C185592680 @default.
• W2400973399 hasConceptScore W2400973399C197404232 @default.
• W2400973399 hasConceptScore W2400973399C22814914 @default.
• W2400973399 hasConceptScore W2400973399C2776672577 @default.
• W2400973399 hasConceptScore W2400973399C28005876 @default.
• W2400973399 hasConceptScore W2400973399C32264632 @default.
• W2400973399 hasConceptScore W2400973399C55493867 @default.
• W2400973399 hasIssue "5" @default.
• W2400973399 hasLocation W24009733991 @default.
• W2400973399 hasOpenAccess W2400973399 @default.
• W2400973399 hasPrimaryLocation W24009733991 @default.
• W2400973399 hasRelatedWork W2008667004 @default.
• W2400973399 hasRelatedWork W2063111947 @default.
• W2400973399 hasRelatedWork W2075329038 @default.
• W2400973399 hasRelatedWork W2102705401 @default.
• W2400973399 hasRelatedWork W2129716367 @default.
• W2400973399 hasRelatedWork W2145275333 @default.
• W2400973399 hasRelatedWork W2155007138 @default.
• W2400973399 hasRelatedWork W2289465086 @default.
• W2400973399 hasRelatedWork W2330884341 @default.
• W2400973399 hasRelatedWork W2400973399 @default.
• W2400973399 hasVolume "124" @default.
• W2400973399 isParatext "false" @default.
• W2400973399 isRetracted "false" @default.
• W2400973399 magId "2400973399" @default.
• W2400973399 workType "article" @default.